The Third Conference on Education in Clinical Chemistry was organized by the Board of Directors of the Commission on Accreditation in Clinical Chemistry (COMACC) and was held at the Sheraton Gateway Suites, O'Hare Airport in Chicago, IL, on September 29 -October 1, 1995. 3 The two previous conferences had been held in Columbus, OH, in 1973 [1] and Chicago, IL, in 1975 [2] ; the 1975 conference had 75 attendees representing 50 institutions.
The Third Conference was cosponsored by the American Association for Clinical Chemistry (AACC), the American Board of Clinical Chemistry (ABCC), and the National Academy of Clinical Biochemistry. Directors of postdoctoral training programs from each COMACCaccredited program were invited to attend, as were Jay McDonald, University of Alabama at Birmingham, who provided the keynote address, and guest speakers representing clinical chemistry opportunities within industry. A total of 30 program directors and guest speakers were present, representing all but 2 of the 19 postdoctoral programs accredited by COMACC at the time. A current listing of COMACC-approved graduate and postdoctoral programs in clinical chemistry is included in Table 1 .
This conference was organized in response to new educational needs brought about by dramatic changes in the delivery of laboratory medicine. Many groups have documented this reform. In 1995, the AACC Board of Directors formed a Task Force to examine the current practice environment, estimate future practices, list professional qualifications necessary to meet anticipated practices, and recommend programs to enable clinical chemists to gain the required competencies [3] . As listed by the Task Force, the skills needed today are in the areas of clinical (for test logic, appropriateness, and consultation), scientific and technical (in automation, informatics, and robotics), and management (for multidisciplinary team-building and leadership). A new task force (Delta) has been created and its members are now meeting to address specific means by which core competencies can be achieved. Almost simultaneously, a second group of clinical chemists, naming themselves the Athena Society, met in Rhodes, Greece, in September 1995, and Fullerton, CA, in July 1996. While they came to the same general conclusions as the AACC Task Force, they listed specialty areas where the core competencies were needed [4] . The Athena Society stressed the need for reform in basic training programs for students and the establishment of programs for the retraining of practicing clinical chemists. Because COMACC is responsible for accrediting clinical chemistry training programs in the US, the Third Conference on Education was convened to discuss how the existing curriculum of postdoctoral clinical chemistry training programs could be expanded to meet the changing practice environment and to make graduates of accredited programs more competitive for employment opportunities within the field. (A similar multiorganization effort was recently conducted for modification of clinical pathology residency training programs [5] .) Keynote Address: Need for Interdisciplinary Training (Jay McDonald, Speaker)
The future economics of healthcare no longer allows anyone the luxury of hiring specific individuals to head a single laboratory subspecialty [6] . As chairman of a Department of Pathology, the keynote speaker stated that, when positions are vacant in his department, he seeks the most qualified individuals irrespective of their doctoral degrees (e.g., M.D., Ph.D., D.Sc.). Those who are capable of applying their training to all areas of the laboratory, and who can make contributions outside the department (e.g., through committees on managed care, medical quality assurance, physician utilization of services) are particularly desirable. There appeared to be a consensus among . Postdoctoral training objectives must be broadened in scope to meet the current needs of industry, particularly in nontechnical areas such as management, fiscal and policy development, and regulatory affairs. Job opportunities currently present in industry include product development, systems integration, clinical evaluations, research and reagent programs, quality assurance, regulatory affairs, quality control, and customer technical support.
Reference laboratories, like every other segment of healthcare, are also undergoing considerable consolidation and realignment of testing as a consequence of changing customer needs. Training should be more directed towards establishing a "quality product mentality." Traditionally trained chemists who enter industry have little supervisory training experience and often do not know how to stay within budget limits and time deadlines. The importance of management training was stressed by both speakers. The participants of the conference felt that one mechanism to address this need was to develop and (or) sponsor a professional course on business management training, to be made available at an annual meeting. This topic will be explored further by COMACC.
Industry externships (Hermant Vaidya, Dade International, Newark, DE, and Pauline Lau, Boehringer Mannheim Diagnostics, Indianapolis, IN). An externship industry rotation involves sending a postdoctoral fellow offsite to a diagnostics company or reference laboratory after at least 1 year of clinical chemistry training in an accredited program. The fellow would then return to the laboratory for completion of the fellowship. During the externship, the corporate sponsor would be responsible for the fellow's stipend and training expenses. It may also be necessary to arrange for temporary housing if the fellow cannot commute from his or her primary residence. Because most fellows have no prior experience in the corporate environment, an externship could be the first step towards acquiring a permanent position within industry. On the other hand, the potential industry employer would get an opportunity to work with a fellow without having to make a long-term commitment to that individual. Other potential benefits of an externship to both parties are listed on Table 2 .
Fellows would ideally be exposed to the product development process, beginning with product definition and proceeding through research and development, regulatory and marketing concerns, and manufacturing. Clinical chemists are also needed for product support, technology assessment, new business development, and strategic planning. Postdoctoral fellows interested in industry often have a general lack of business training and marketing experience and may have narrow research interests. An externship could give fellows the insights needed to compete in this area. The estimated time needed for an effective exposure would be 6 -12 months.
The merits of having industry scientists and marketing individuals spend some time within a hospital laboratory were also discussed as a means to foster collaborations between industry and academia and to provide some alternative funding sources for the teaching institutions. Several members of COMACC voiced positive experiences in exchange programs between their institution and private industry.
training in nontraditional testing areas (chair: roland valdes, jr., university of louisville, ky)
Point-of-care testing (Mary Burritt, Mayo Clinic, Rochester, MN). Leadership in this area is lacking in many hospitals and medical centers. Point-of-care (POC) testing is a growth opportunity for clinical chemists and doctoral scientists. A broad background is needed for successful supervision of this testing. Competency is needed in areas such as testing for critical care medicine, the technology of POC monitoring and testing devices, and clinical and laboratory experience in the areas of coagulation testing, hematology, urinalysis, and microscopy. Equally important is the knowledge in quality control/assurance, financial management, outcomes assessment, cost/benefit analysis, and information transfer technology. Trainees must also be current with regard to the rapidly evolving regulations that surround these testing services. Effective delivery of POC testing requires individuals who understand patients' needs. POC testing is a unique opportunity for laboratory scientists to get acquainted with patients, physicians, and all members of the healthcare team.
Core laboratory concept (Frank Sedor, Duke University Medical Center, Durham, NC). A core laboratory provides all continual laboratory services necessary to a hospital on a 24-h basis, irrespective of traditional boundaries of laboratory medicine subspecialties. As such, a typical core laboratory would combine chemistry, hematology, coagulation, urinalysis, and serology into one facility [7] . Intuitively, the core laboratory should require less administrative, supervisory, and technology personnel. Moreover, turnaround times for reporting test results should be improved with the establishment of a central processing area at or adjacent to the core laboratory. Many large hospitals have reengineered their space and supervisory responsibilities to adopt the core laboratory concept, and many more hospitals are in the planning stages for such a development.
For years, small hospitals have operated under a single-laboratory concept: Because of low testing volumes, it was not cost effective to diversify the management responsibility. Such institutions, however, are generally not involved with postdoctoral clinical chemistry training. Even if the host institution does not actually operate a core laboratory, program directors must begin to develop formal goals and objectives for teaching clinical chemistry fellows the basic concepts in these nontraditional areas. Expansion of the program's teaching faculty will probably be necessary to provide the expertise needed to instruct in this area. Training should be focused on the information needed to direct the delivery of "stat" laboratory services and should not attempt to train fellows to become specialists in these areas. Individuals trained as a laboratory scientist should not directly compete against specialists in microbiology, hematology, and immunology for jobs. Nevertheless, the conference participants felt that there will be some degree of resistance by the non-clinicalchemistry faculty to provide this education to clinical chemistry fellows.
Molecular diagnostics (Lawrence Silverman, University of North Carolina Hospitals and Clinics, Chapel Hill, NC).
One field open to subspecialization for clinical chemists is molecular diagnostics. The training objectives of the University of North Carolina program are as follows: meeting eligibility requirements for the American Board of Medical Genetics; research and development (fellows must develop at least one molecular test); teaching (in the medical genetics course for second-year medical students); cross-training in other areas of molecular pathology (microbiology, hematology, HLA tissue typing, genetics rotation); and research in a selected area, leading to presentation and (or) publication. This 3-year program contains 6 months in general clinical chemistry, 6 months in a selected area, 1 year in the DNA diagnostic laboratory, and 1 year in a genetics rotation (including cytopathology, biochemistry, and clinical genetics). The third year is necessary for applicants to qualify for the American Board of Medical Genetics certification examination. Program directors should direct rotations within molecular diagnostic laboratories, irrespective as to where (within the hierarchy and politics of the Department of Pathology) such testing is being conducted. Other areas of molecular pathology that could be part of a training program for clinical chemists include infectious disease, cancer diagnoses, identity testing (forensic and paternity), and tissue diagnosis. Some changes may be necessary in the qualifications of candidates applying to postdoctoral fellowships that have a molecular diagnostics component. The COMACC and ABCC currently require fellows to have at least 1 year of a graduate school-level biochemistry course. Additional training and (or) experience in molecular biology may also become a requirement for future fellows.
research training (chair: mitchell g. scott, washington university, st. louis, mo)
Research continues to be important in the training of postdoctoral fellows. Knowledge and hands-on experience of investigative principles and techniques are important for assessing and improving laboratory services in the current practice environment of clinical chemistry. Fellows should have experience in critical literature review, experimental design, statistics, data analysis, and presentation. Research expertise is essential for getting jobs in academia and industry (including reference laboratories), the two areas where employment opportunities continue to exist for recent graduates [8] . The majority of recent graduates of the Washington University program have obtained employment largely because of their demonstration of research productivity. The ability to obtain external funding is also important in securing employment, although this should not be a major focus of the training program. Issues under consideration regarding research include what types of investigations make the clinical chemist most attractive in the job market (i.e., basic science, applied research and development, or clinical trials), and what percentage of time should be allotted for conducting research and for attending research seminars, journal clubs, and scientific meetings. Most programs continue to maintain considerable research involvement, especially during the second year and beyond, with an expectation that results of such work will be presented at scientific meetings and submitted to peerreviewed journals.
training in medical informatics and laboratory management
Informatics and automation (Robert Burnett, Hartford Hospital, Hartford, CT). Management of medical laboratory data is essential for the effective delivery of services. Medical informatics is a broad field that incorporates computer science, decision science, library science, cognitive science, and various aspects of engineering. Management of data is critical to the success of any clinical laboratory. Trainees in clinical chemistry, in particular, must have exposure and working knowledge in hospital and laboratory information systems, database management systems, networked systems, and application software for word processing, spreadsheets, presentation graphics, statistics, electronic mail, and literature searching. In the era of limited managed-care reimbursements, there will be an increasing emphasis on the effective utilization of testing services through research in outcomes analyses. Laboratory scientists will be responsible for generating utilization data and controlling physicians' test-ordering patterns. Expert systems are being developed to deliver information in the most efficient manner possible. Conference participants recognized that formal Clinical Chemistry 43, No. 1, 1997 training of medical informatics is currently lacking in the majority of COMACC-accredited programs.
Total laboratory automation is an emerging science and will be central to the efficient delivery of laboratory information. Initial hardware and software designs are tasks for engineers and computer science personnel, but effective implementation will require the collaborative efforts of clinical laboratory scientists and administrators. Although robotics has been fairly successful in large Japanese clinical laboratories, implementation in the US has been largely limited to reference laboratories, with a few large hospitals now considering total automation [9] . If robotics becomes a mainstay of laboratory operation, it will be necessary for postdoctoral fellows to have experience in this area. Until more hospitals and medical centers commit to automation, however, an off-site externship may be the only route by which postdoctoral fellows can enter this emerging field.
Laboratory management training (Michael G. Bissell, University of Texas Medical Branch, Galveston, TX). Specific curricular objectives that could be included in future postdoctoral training programs of laboratory management are: basic management concepts, history of the clinical laboratory industry, applied healthcare economics, problem-solving and decision theory, human resource management, legal and regulatory affairs, psychology of laboratory management, and quality improvement and futuristics. Basic management includes organization theory and concepts. Effective management of human resources and an understanding of labor principles is the pinnacle for laboratory administration. Knowledge of business and labor law, and of regulations and licensure, is also part of management that must be conveyed to the trainee. Theories and practices of total quality improvement are basic to any service or business environment. Laboratory management has always been a major objective for postdoctoral education, although different CO-MACC programs display great variability in the delivery of this training. Because most fellows consider management education a low priority, innovative teaching techniques are needed to motivate postdoctoral fellows to learn these concepts.
Discussion
Whereas funding and lack of qualified candidates were the major concerns for directors of clinical chemistry training programs a decade ago, the major issue in the US today is the lack of jobs for graduating fellows. In light of these realities, many fine long-standing institutions such as Louisiana State University (New Orleans) and Ohio State University (Columbus) are no longer offering COMACC-accredited graduate (masters and doctoral) programs in clinical chemistry. Many postdoctoral training programs have either temporarily suspended attempts to fill their vacant slots or reduced the numbers of trainees enrolled. Although the total number of COMACC-accredited training programs has remained remarkably steady over the past decade, the number of students entering the field of clinical chemistry has decreased. Until there is stabilization of the healthcare industry, this trend is likely to continue.
The inclusion of several new objectives (such as those listed in this document) into the curriculum of clinical chemistry training programs may help make clinical chemistry fellows more marketable in today's practice environment. It may be necessary to extend the duration of current COMACC-accredited programs from 2 to 3 years. Many programs are already 3 years long (e.g., Washington University, University of Louisville, and the former program at the Health Science Centre in Winnipeg, Manitoba, Canada). The Washington University and Louisville programs are geared to train fellows for teaching hospitals, with the third year being largely devoted to research. In the pioneering Winnipeg Health Science Centre program, the additional year was spent exposing fellows to anatomic pathology (including the autopsy service) and many of the nontraditional areas of the clinical laboratory discussed above. For programs that have only an occasional fellow, increasing the duration to 3 years will require an additional upfront commitment for funding. For programs that have a continual enrollment of postdoctoral fellows every 2 years, a 3-year training program will reduce the total numbers of graduates who finish and enter the field but will not require additional financial support. Considering the decrease in employment listings for clinical chemists over the past few years, the slowing of graduates entering the field was viewed as being favorable. After subsequent discussion, commissioners of COMACC and program directors decided that COMACC could not move to require programs to adopt a 3-year curriculum. Nevertheless, COMACC will be encouraging an expansion of training objectives to meet the needs of the current practice environment. As before, it is incumbent on individual fellows to seek a program that best suits their needs.
Alterations in the training of clinical chemists will have an impact on certification of graduates by ABCC. Of particular issue is the role ABCC may play in certification of competency for molecular diagnostics. In the most recent meeting, the Board ruled that future chemistry examinations will contain questions on molecular diagnostics. Another issue discussed by the group was the qualifications of candidates who sit for the ABCC clinical chemistry examination. Under the current regulation, any individual who has been engaged in full-time practice of clinical chemistry in the US for 5 years is qualified to take the certification examination. However, the majority of the group felt that, after a "grandfathering" period, only graduates of COMACC-accredited programs (or foreign training programs deemed equivalent by COMACC and ABCC) should be allowed to take the examination and become certified. Such a practice would be consistent with the majority of other medical certification bodies (e.g., the American Board of Pathology). A recommendation to this effect was forwarded by COMACC to ABCC for consideration, and the recommendation was motioned and approved by ABCC at its last meeting.
